BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 1690313)

  • 21. [Molecular mimicry between neurofilaments and titin as the basis for autoimmunity towards skeletal muscle in paraneoplastic myasthenia gravis].
    Wilisch A; Schultz A; Greiner A; Kirchner T; Müller-Hermelink HK; Marx A
    Verh Dtsch Ges Pathol; 1996; 80():261-6. PubMed ID: 9065023
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of human anti-acetylcholine receptor monoclonal autoantibodies from the peripheral blood of a myasthenia gravis patient using combinatorial libraries.
    Rey E; Zeidel M; Rhine C; Tami J; Krolick K; Fischbach M; Sanz I
    Clin Immunol; 2000 Sep; 96(3):269-79. PubMed ID: 10964546
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interaction of monoclonal antibodies to Torpedo acetylcholine receptor with the receptor of skeletal muscle.
    Souroujon MC; Mochly-Rosen D; Gordon AS; Fuchs S
    Muscle Nerve; 1983 May; 6(4):303-11. PubMed ID: 6866010
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Humoral immunity in myasthenia gravis: biochemical characterization of acquired antireceptor antibodies and clinical correlations.
    Tindall RS
    Ann Neurol; 1981 Nov; 10(5):437-47. PubMed ID: 7305297
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Autoimmunizing mechanisms in thymoma and thymus.
    Willcox N; Leite MI; Kadota Y; Jones M; Meager A; Subrahmanyam P; Dasgupta B; Morgan BP; Vincent A
    Ann N Y Acad Sci; 2008; 1132():163-73. PubMed ID: 18567866
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Determinant selection in murine experimental autoimmune myasthenia gravis. Effect of the bm12 mutation on T cell recognition of acetylcholine receptor epitopes.
    Infante AJ; Thompson PA; Krolick KA; Wall KA
    J Immunol; 1991 May; 146(9):2977-82. PubMed ID: 1707927
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Specificity of the T cell immune response to acetylcholine receptor in experimental autoimmune myasthenia gravis. Response to subunits and synthetic peptides.
    Fujii Y; Lindstrom J
    J Immunol; 1988 Mar; 140(6):1830-7. PubMed ID: 2450133
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A juxta-membrane epitope on the human acetylcholine receptor recognized by T cells in myasthenia gravis.
    Harcourt GC; Sommer N; Rothbard J; Willcox HN; Newsom-Davis J
    J Clin Invest; 1988 Oct; 82(4):1295-300. PubMed ID: 2459161
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antimuscle and antiacetylcholine receptor antibodies in myasthenia gravis.
    Penn AS; Schotland DL; Lamme S
    Muscle Nerve; 1986 Jun; 9(5):407-15. PubMed ID: 3724787
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Antibodies in myasthenia gravis].
    Eymard B
    Rev Neurol (Paris); 2009 Feb; 165(2):137-43. PubMed ID: 19162288
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular aspects of experimental autoimmune myasthenia gravis.
    Fuchs S; Bartfeld D; Mochly-Rosen D; Schmidt-Hopfeld I; Tarrab-Hazdai R
    Prog Clin Biol Res; 1981; 63():405-17. PubMed ID: 7031685
    [TBL] [Abstract][Full Text] [Related]  

  • 32. TCR V beta usage by acetylcholine receptor-specific CD4+ T cells in myasthenia gravis.
    Raju R; Navaneetham D; Protti MP; Horton RM; Hoppe BL; Howard J; Conti-Fine BM
    J Autoimmun; 1997 Apr; 10(2):203-17. PubMed ID: 9185882
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Myasthenia gravis. Residues of the alpha and gamma subunits of muscle acetylcholine receptor involved in formation of immunodominant CD4+ epitopes.
    Moiola L; Protti MP; McCormick D; Howard JF; Conti-Tronconi BM
    J Immunol; 1994 May; 152(9):4686-98. PubMed ID: 7908921
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acetylcholine receptor antibodies in myasthenia gravis.
    Kornfeld P; Nall J; Smith H; Mittag TW; Bender AN; Ambinder EP; Horowitz SH; Papatestas AE; Gross H; Genkins G
    Muscle Nerve; 1981; 4(5):413-9. PubMed ID: 6974823
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Abnormal T cell maturation in myasthenia gravis associated thymomas].
    Nenninger R; Schultz A; Müller-Hermelink HK; Marx A
    Verh Dtsch Ges Pathol; 1996; 80():256-60. PubMed ID: 9065022
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Autoimmune T lymphocytes in myasthenia gravis. Determination of target epitopes using T lines and recombinant products of the mouse nicotinic acetylcholine receptor gene.
    Melms A; Chrestel S; Schalke BC; Wekerle H; Mauron A; Ballivet M; Barkas T
    J Clin Invest; 1989 Mar; 83(3):785-90. PubMed ID: 2466050
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetic restriction of autoreactive acetylcholine receptor-specific T lymphocytes in myasthenia gravis.
    Hohlfeld R; Conti-Tronconi B; Kalies I; Bertrams J; Toyka KV
    J Immunol; 1985 Oct; 135(4):2393-9. PubMed ID: 2411794
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Heterogeneity of acetylcholine receptors: different forms of receptor distinguished by alpha-bungarotoxin kinetics and by antibody binding properties.
    Massa T; Mittag TW
    J Pharmacol Exp Ther; 1983 Nov; 227(2):340-8. PubMed ID: 6631716
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A rapid, fluorescence-based assay for detecting antigenic modulation of the acetylcholine receptor on human cell lines.
    Keefe D; Hess D; Bosco J; Tzartos S; Powell J; Lamsa J; Josiah S
    Cytometry B Clin Cytom; 2009 May; 76(3):206-12. PubMed ID: 18825779
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Spontaneous production of anti-IFN-alpha and anti-IL-12 autoantibodies by thymoma cells from myasthenia gravis patients suggests autoimmunization in the tumor.
    Shiono H; Wong YL; Matthews I; Liu JL; Zhang W; Sims G; Meager A; Beeson D; Vincent A; Willcox N
    Int Immunol; 2003 Aug; 15(8):903-13. PubMed ID: 12882828
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.